USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: IMMTECH INTERNATIONAL, INC.
City: VERNON HILLS
State: IL
Zip+4: 60061 0186
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (847) 573-0033

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $204,055.00 5
SBIR Phase II $1,927,658.00 3
STTR Phase I $197,292.00 2

Award List:

IMMUNE COMPLEX BINDING BY MODIFIED C-REACTIVE PROTEIN

Award Year / Program / Phase: 1988 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $50,000.00
Abstract:
Immune complexes (ics) are formed by the binding of antibodies with antigens, the antigens being components of infectious organisms, other molecules foreign to the host organism, tumor-associated molecules, and in many diseases, normal tissue molecular components. ics are removed from the… More

QUANTITATIVE ASSESSMENT OF SUSTAINED ALCOHOL USAGE

Award Year / Program / Phase: 1990 / SBIR / Phase I
Agency: HHS
Principal Investigator: Samar Makhlouf
Award Amount: $47,055.00

QUANTITATIVE ASSESSMENT OF SUSTAINED ALCOHOL USAGE

Award Year / Program / Phase: 1993 / SBIR / Phase II
Agency: HHS
Principal Investigator: Samar Makhlouf
Award Amount: $498,203.00
Abstract:
Alcohol usage over time results in a number of metabolic alterations to several organ systems, including changes in liver function. one of the latter changes is the production and secretion into the blood of an isoform of thetransferrin molecule. the pi 5.7-transferrin isoform can bedetected by… More

ORALLY ACTIVE PRODRUGS FOR TROPICAL PARASITIC INFECTIONS

Award Year / Program / Phase: 1998 / STTR / Phase I
Agency: HHS
Research Institution: Georgia State University
Principal Investigator: Boykin
Award Amount: $100,000.00
RI Contact: N/A

IMMUNOASSAYS FOR PENTAMIDINE LIKE (DICATIONIC) DRUGS

Award Year / Program / Phase: 1998 / STTR / Phase I
Agency: HHS
Research Institution: University of North Carolina
Principal Investigator: Reisner
Award Amount: $97,292.00
RI Contact: N/A

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $0.00

N/A

Award Year / Program / Phase: 1999 / SBIR / Phase II
Agency: HHS
Principal Investigator:
Award Amount: $796,638.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase I
Agency: HHS
Principal Investigator: James L. Allen
Award Amount: $0.00

N/A

Award Year / Program / Phase: 2000 / SBIR / Phase II
Agency: HHS
Principal Investigator: James L. Allen
Award Amount: $632,817.00

Aromatic Dication Prodrugs for CNS Trypanosomiasis

Award Year / Program / Phase: 2004 / SBIR / Phase I
Agency: HHS
Principal Investigator: James L. Allen
Award Amount: $107,000.00
Abstract:
DESCRIPTION (provided by applicant): The long-range research goal is to develop a new drug to treat secondary (central nervous system) stage human African trypanosomiasis. Previous SBIR supported research identified DB289, a methoxime prodrug of the aromatic dication furamidine, that is currently… More